Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | QDPR | P09417 | 2/20 | 0.43 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.42 |
| ▸ | GAK | O14976 | 1/20 | 0.41 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.40 |
| ▸ | TUBB | P07437 | 1/20 | 0.40 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.40 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.40 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.40 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.40 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.40 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.40 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.40 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.40 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.40 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20225757 | 0.88 | ALDH1A1 (0.53) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL4766178 | 0.87 | TUBB4A (0.50) | ALDH1A1CYP3A4TDP1QDPRNR3C1 | |
| SCHEMBL20073494 | 0.85 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL522340 | 0.83 | IRAK4 (0.44) | ALDH1A1CYP3A4QDPR | |
| SCHEMBL522383 | 0.83 | IRAK4 (0.44) | ALDH1A1CYP3A4QDPR | |
| SCHEMBL522339 | 0.83 | IRAK4 (0.44) | ALDH1A1CYP3A4QDPR | |
| SCHEMBL27715450 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL19174939 | 0.83 | KCNH2 (0.37) | ALDH1A1HSD17B10GAKCHEK1IL2 | |
| SCHEMBL310290 | 0.82 | HTR2C (0.55) | ALDH1A1CYP3A4TSHRHSD17B10TDP1 | |
| SCHEMBL12856197 | 0.82 | QDPR (0.44) | ALDH1A1QDPRNR3C1CHEK1IL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12002944-B2 | Method for manufacturing electrode comprising polymeric solid electrolyte and electrode obtained thereby | LG ENERGY SOLUTION, LTD. (KR) | 2024-06-04 | — | — | US | claimed |
| CN-104558160-B | The solid phase synthesis process of Angiomax intermediate | 上海第生化药业有限公司 | 2018-01-16 | — | — | CN | claimed |
| CN-108178736-A | A large amount of synthetic methods for preparing α-vinyl azide compounds | 东北师范大学 | 2018-06-19 | — | — | CN | disclosed |
| US-7728090-B2 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2010-06-01 | — | — | US | disclosed |
| WO-2010049731-A1 | PYRAZOLO- AND IMIDAZOPYRIDINYLPYRIMIDINEAMINES AS IGF-1R TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010049731-A1 | PYRAZOLO- AND IMIDAZOPYRIDINYLPYRIMIDINEAMINES AS IGF-1R TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2010-05-06 | — | — | WO | disclosed |
| US-20100105655-A1 | NOVEL COMPOUNDS 515 | ASTRAZENECA AB | 2010-04-29 | — | — | US | disclosed |
| US-7323518-B2 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2008-01-29 | — | — | US | disclosed |
| US-7309751-B2 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2007-12-18 | — | — | US | disclosed |
| US-7271223-B2 | Norbomene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2007-09-18 | — | — | US | disclosed |
| US-7271230-B2 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2007-09-18 | — | — | US | disclosed |
| US-20070073018-A1 | Norbornene compounds with cross-linkable groups and their derivatives | LIAW DER-JANG | 2007-03-29 | — | — | US | disclosed |
| US-20070073079-A1 | Norbornene compounds with cross-linkable groups and their derivatives | LIAW DER-JANG | 2007-03-29 | — | — | US | disclosed |
| US-20070073080-A1 | Norbornene compounds with cross-linkable groups and their derivatives | LIAW DER-JANG | 2007-03-29 | — | — | US | disclosed |
| US-20070073017-A1 | Norbornene compounds with cross-linkable groups and their derivatives | LIAW DER-JANG | 2007-03-29 | — | — | US | disclosed |
| US-20070066774-A1 | Norbornene compounds with cross-linkable groups and their derivatives | LIAW DER-JANG | 2007-03-22 | — | — | US | disclosed |
| US-7132565-B2 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2006-11-07 | — | — | US | disclosed |
| US-20050182218-A1 | Norbornene compounds with cross-linkable groups and their derivatives | NATIONAL TAIWAN UNIVERSITY OF SCIENCE & TECHNOLOGY (TW) | 2005-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070073080-A1 | Norbornene compounds with cross-linkable groups and their derivatives | OXER1, SQLE, ALOX12 | ALDH1A1 638/4885CYP3A4 598/4885TSHR 4131/4885 |
| US-20070073079-A1 | Norbornene compounds with cross-linkable groups and their derivatives | OXER1, SQLE, ALOX12 | ALDH1A1 638/4885CYP3A4 598/4885TSHR 4131/4885 |
| US-20100105655-A1 | NOVEL COMPOUNDS 515 | TYMS, ABCG2, UMPS | ALDH1A1 649/4885CYP3A4 49/4885TSHR 3512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.